Search Results - "Zatorski, H"

  • Showing 1 - 10 results of 10
Refine Results
  1. 1

    Relamorelin and other ghrelin receptor agonists - future options for gastroparesis, functional dyspepsia and proton pump inhibitors-resistant non-erosive reflux disease by Zatorski, H, Mosinska, P, Storr, M, Fichna, J

    “…There is an unmet need for effective pharmacological therapies for the treatment of gastroparesis and other upper gastrointestinal (GI) motility disorders,…”
    Get more information
    Journal Article
  2. 2

    Selective inhibition of FAAH produces antidiarrheal and antinociceptive effect mediated by endocannabinoids and cannabinoid‐like fatty acid amides by Fichna, J., Sałaga, M., Stuart, J., Saur, D., Sobczak, M., Zatorski, H., Timmermans, J. ‐P., Bradshaw, H. B., Ahn, K., Storr, M. A.

    Published in Neurogastroenterology and motility (01-04-2014)
    “…Background The endogenous cannabinoid system (ECS) plays a crucial role in multiple physiological processes in the central nervous system and in the periphery…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Highly selective CB2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice by Salaga, M., Zatorski, H., Zielińska, M., Mosinska, P., Timmermans, J-P., Kordek, R., Storr, M., Fichna, J.

    “…Cannabinoid type 2 (CB 2 ) receptors are distributed in central and peripheral tissues, including immunocytes and the gastrointestinal (GI) tract, suggesting…”
    Get full text
    Journal Article
  5. 5
  6. 6

    High activity of endogenous opioid system protects against gastric damage development in mouse models of gastric mucosal injury by Zatorski, Hubert, Salaga, Maciej, Zielińska, Marta, Wasilewski, Andrzej, Misicka, Aleksandra, Sacharczuk, Mariusz, Fichna, Jakub

    Published in Pharmacological reports (01-04-2019)
    “…Gastric mucosal injury appears when acid and pepsin production, simultaneously with inadequate mucosal response, overwhelms protective mechanism in stomach…”
    Get more information
    Journal Article
  7. 7

    Highly selective CB^sub 2^ receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice by Salaga, M, Zatorski, H, Zielińska, M, Mosinska, P, Timmermans, J-p, Kordek, R, Storr, M, Fichna, J

    “…Cannabinoid type 2 (CB2) receptors are distributed in central and peripheral tissues, including immunocytes and the gastrointestinal (GI) tract, suggesting…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Highly selective CB 2 receptor agonist A836339 has gastroprotective effect on experimentally induced gastric ulcers in mice by Salaga, M, Zatorski, H, Zielińska, M, Mosinska, P, Timmermans, J-P, Kordek, R, Storr, M, Fichna, J

    “…Cannabinoid type 2 (CB ) receptors are distributed in central and peripheral tissues, including immunocytes and the gastrointestinal (GI) tract, suggesting…”
    Get full text
    Journal Article
  10. 10

    Performance Evaluation of Dynamic Monitoring Systems: The Waterfall Chart by Box, George, Bisgaard, Søren, Graves, Spencer, Kulahci, Murat, Marko, Ken, James, John, Van Gilder, John, Ting, Tom, Zatorski, Hal, Wu, Cuiping

    Published in Quality engineering (12-01-2003)
    “…Computers are increasingly employed to monitor the performance of complex systems. An important issue is how to evaluate the performance of such monitors. In…”
    Get full text
    Journal Article